 Glen Rock, N.J., Jan. 23, 2023 GLOBE NEWSWIRE RespireRx Pharmaceuticals Inc. OTC Markets: RSPI RespireRx or the Company, a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce that the Company and the Board of Trustees of University of... The post RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois appeared f... 